Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

Human Stem Cell Graft Stimulates Neuron Regeneration in Rats with Spinal Injury

By BiotechDaily International staff writers
Posted on 06 Jun 2013
Image: A three-dimensional, reconstructed magnetic resonance image (upper) shows a cavity caused by a spinal injury nearly filled with grafted neural stem cells, colored green. The lower image depicts neuronal outgrowth from transplanted human neurons (green) and development of putative contacts (yellow dots) with host neurons (blue) (Photo courtesy of the University of California, San Diego School of Medicine).
Image: A three-dimensional, reconstructed magnetic resonance image (upper) shows a cavity caused by a spinal injury nearly filled with grafted neural stem cells, colored green. The lower image depicts neuronal outgrowth from transplanted human neurons (green) and development of putative contacts (yellow dots) with host neurons (blue) (Photo courtesy of the University of California, San Diego School of Medicine).
Image: Senior author Dr. Martin Marsala (Photo courtesy of the University of California, San Diego School of Medicine).
Image: Senior author Dr. Martin Marsala (Photo courtesy of the University of California, San Diego School of Medicine).
Human neural stem cells injected into rats with acute spinal cord injury generated connections between the injected stem cells and surviving host neurons, which stimulated host neuron regeneration and partially replaced the neurons destroyed by the injury.

Investigators at the University of California, San Diego School of Medicine (USA) worked with a model system comprising three-month-old female Sprague-Dawley rats with induced spinal compression injury. Three days postinjury, the animals were randomized and some received intraspinal injections of either human fetal spinal cord-derived neural stem cells (HSSC) or media-only, or did not receive an injection. All animals were immunosuppressed from the day of cell grafting and survived for eight weeks.

Results published in the May 28, 2013, online edition of the journal Stem Cell Research & Therapy revealed that the intraspinal grafting of HSSC in the injured animals led to a progressive and significant improvement in lower extremity paw placement, amelioration of spasticity, and normalization in thermal and tactile pain/escape thresholds at eight weeks post-grafting. Magnetic resonance imaging volume reconstruction and immunofluorescence analysis of grafted cell survival showed near complete injury-cavity-filling by grafted cells and development of putative synapses between grafted and host neurons.


Channels

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Lab Technologies

view channel
Image: The FLUOVIEW FVMPE-RS Gantry microscope (Photo courtesy of Olympus).

New Multiphoton Laser Scanning Microscope Configurations Expand Research Potential

Two new configurations of a state-of-the-art multiphoton laser scanning microscope extend the usefulness of the instrument for examining rapidly occurring biological events and for obtaining images from... Read more

Business

view channel

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche (Basel, Switzerland) will advance translational research for next generation sequencing (NGS) diagnostics by leveraging the unique expertise of Signature Diagnostics AG (Potsdam, Germany) in biobanks and development of novel NGS diagnostic assays. Signature Diagnostics is a privately held translational oncology... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.